Nuvo Pharmaceuticals Inc (MRVFF)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.9795 +0.0045 (+0.46%) 03/13/23 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.9795 unch (unch) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,696 | -3,082 | 2,533 | -4,747 | 1,220 |
| Depreciation Amortization | 6,423 | 6,910 | 7,194 | 1,923 | 199 |
| Income taxes - deferred | 1,917 | N/A | N/A | -174 | N/A |
| Accounts receivable | 799 | 5,670 | -6,761 | -1,075 | 397 |
| Other Working Capital | 3,905 | 3,591 | -10,547 | 3,133 | 1,279 |
| Other Operating Activity | 29,285 | 5,076 | 9,361 | -1,773 | 370 |
| Operating Cash Flow | $16,631 | $18,164 | $1,781 | $-2,712 | $3,464 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 1,543 | 4,628 |
| PPE Investments | -176 | -414 | -63 | -232 | -2,010 |
| Net Acquisitions | N/A | N/A | -1,919 | -106,830 | N/A |
| Purchase Sale Intangibles | -18 | -144 | N/A | N/A | -12 |
| Other Investing Activity | -18 | -144 | 0 | -1,447 | -6,786 |
| Investing Cash Flow | $-193 | $-558 | $-1,982 | $-106,966 | $-4,168 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -10,693 | -16,749 | -2,528 | N/A | N/A |
| Common Stock Issued | N/A | N/A | N/A | 95 | 5 |
| Other Financing Activity | -180 | -189 | -293 | 124,141 | -2 |
| Financing Cash Flow | $-10,872 | $-16,937 | $-2,821 | $124,235 | $4 |
| Exchange Rate Effect | 73 | -80 | -788 | 623 | -219 |
| Beginning Cash Position | 18,996 | 17,184 | 21,157 | 6,479 | 7,397 |
| End Cash Position | 24,634 | 17,772 | 17,347 | 21,659 | 6,478 |
| Net Cash Flow | $5,639 | $588 | $-3,809 | $15,180 | $-919 |
| Free Cash Flow | |||||
| Operating Cash Flow | 16,631 | 18,164 | 1,781 | -2,712 | 3,464 |
| Capital Expenditure | -176 | -414 | -63 | -232 | -2,010 |
| Free Cash Flow | 16,456 | 17,750 | 1,718 | -2,943 | 1,454 |